|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/17 | (2006.01) |
| A61K 38/17 | (2013.01) | ||
| A61K 47/68 | (2017.01) | ||
| A61P 37/04 | (2018.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 38/179 | (2013.01) | ||
| A61P 37/04 | (2006.01) | ||
| A61K 39/3955 | (2013.01) | ||
| A61K 39/00 | (2006.01) | ||
| C07K 16/22 | (2013.01) | ||
| C07K 14/495 | (2006.01) | ||
| A61K2039/505 | (2013.01) | ||
| C07K 14/51 | (2006.01) | ||
| C07K2319/30 | (2013.01) | ||
| C07K 16/22 | (2006.01) | ||
| C07K 14/495 | (2013.01) | ||
| C07K 14/51 | (2013.01) |
| (11) | Number of the document | 3576773 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18747362.4 |
| Date of filing the European patent application | 2018-01-31 | |
| (97) | Date of publication of the European application | 2019-12-11 |
| (45) | Date of publication and mention of the grant of the patent | 2023-10-18 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2018/016148 |
| Date | 2018-01-31 |
| (87) | Number | WO 2018/144542 |
| Date | 2018-08-09 |
| (30) | Number | Date | Country code |
| 201762453413 P | 2017-02-01 | US |
| (72) |
PEARSALL, Robert Scott , US
KUMAR, Ravindra , US
|
| (73) |
Acceleron Pharma Inc. ,
128 Sidney Street, Cambridge, MA 02139,
US
|
| (54) | TGF BETA AND ACTRII ANTAGONISTS FOR USE IN TREATING LEUKEMIA |
| TGF BETA AND ACTRII ANTAGONISTS FOR USE IN TREATING LEUKEMIA |